home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How The Oncogene c-Myc Controls Regulation Of Cell Proliferation

  April, 5 2001 3:27
your information resource in human molecular genetics

The oncogene c-Myc regulates cell proliferation, growth and cell death in normal cells. New work by Martin Eilers and colleagues, Universitaet Marburg, Germany and Joan Massagué and colleagues, Sloan-Kettering Cancer Center, New York, published in the April 2001 issue of Nature Cell Biology (3:392-399 and 3:400-408) respectively shed light on how this regulation is controlled.

p15Ink4b is a cyclin-dependent kinase (Cdk) inhibitor which is rapidly activated by the growth factor TGFb. This contributes towards inhibition of the cell division cycle.

Eilers and colleagues showed that Miz-1, a Myc-associated transcription factor, induces p15Ink4b expression and hence leads to inhibition of cell cycle progression. Myc can forms a complex with Miz, which inhibits it’s activity and prevents the accumulation of p15Ink4b. They go onto show that Myc prevents Miz activating gene expression by interfering with the recruitment of p300 (a transcription co-activator) to Miz-1. Myc mutant proteins that cannot bind Miz are unable to inhibit p15Ink4b accumulation which eventually leads to cellular immortalisation. Also Massagué and colleagues showed that TGFb prevents Myc recruitment to Miz, and hence relieves the repression which Myc would usually place on Miz.

Potential targets for cancer therapy may be uncovered from these studies.


Martin Eilers
tel + 49 6421 28 6410
fax + 6421 28 5196
email: eilers@imt.uni-marburg.de

Joan Massagué
tel + 1 212 639 8975
fax + 1 212 717 3298
email: j-massague@ski.mskcc.org

(C) Nature Cell Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.